Therapeutic Approaches for Alzheimer’s Disease: New Perspectives

Alzheimer’s disease (AD) was defined as a neurodegenerative disorder, being more affected in the elderly. It is estimated that every 3.2 seconds a person in the world is affected by the high disease that rate in 2050 to 1 second. Therefore, research has been carried out on new therapeutic approaches...

Full description

Saved in:
Bibliographic Details
Main Authors: Kerppers, Ivo Ilvan, Hosni, Andressa Panegalli, Miri, Andressa Leticia, Cordeiro, Maria Elvira Ribeiro, Kerppers, Flávio Klinpovous, Lima, Mariane Maria Silveira Vieira de, Bini, Ana Carolina Dorigoni, Moreira, Felipe Figueiredo, Suckow, Patricia Pacheco Tyski, Fonseca, Eliane Gonçalves de Jesus, Bernardi, Larissa Sakis, Oliveira, Paulo Renato de
Format: Book Chapter
Language:English
Published: IntechOpen 2021
Subjects:
Online Access:https://www.intechopen.com/chapters/76042
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Alzheimer’s disease (AD) was defined as a neurodegenerative disorder, being more affected in the elderly. It is estimated that every 3.2 seconds a person in the world is affected by the high disease that rate in 2050 to 1 second. Therefore, research has been carried out on new therapeutic approaches, such as Transcranial Photobiomodulation and treatment based on antioxidants, such as Resveratrol. Therefore, the objective is to conduct a literature review on these two approaches and their effects on the treatment of AD. It was carried out according to the PRISMA recommendation and the articles were selected according to the years of publication (between 2015 and 2020) and extracted from the following databases: Science Direct, PubMed PMC, Scopus, PubMed NCBI, SciELO, LILACS, MEDLINE and PEDro. In several studies it has been reported that both therapies provide improvements at the molecular and behavioral level, recovering brain functions, acting in a neuroprotective way, improving quality of life, with few adverse effects and in a less invasive way. Thus, both treatments have numerous benefits that can be useful in the treatment of AD. However, there is a need for further research that includes interventions with greater specificity and control, so that they are defined as ideal doses and treatment protocols.
ISBN:978-1-83969-297-0
DOI:10.5772/intechopen.97081